Rhizome ads, reviews and marketing in August 2026
They market Rhizome AI as a healthcare regulatory research assistant built around FDA answers, broad source coverage, and fast document search. Their 7 newest ads favor static claims and free entry over detailed proof of how results are checked. You can take ground by demonstrating one end-to-end regulatory task, exposing source provenance, and setting clearer expectations for answer quality.
- Researched
- 29 August 2026
- Site
- rhizomeai.com
- Ads read in
- US
- Sources
- 2 of 9 answered
- 10
- ads found
- 0
- reviews found
- 2
- sources read
- Not rated
- review rating
Best opening
Positioning
5 of their 7 ads focus on FDA and regulator questions, so choose a distinct high-value workflow rather than competing on generic AI research.
Moves worth carrying forward
Creative
5 of their 7 ads are static claim formats, so show the product handling a real document-search task from question to cited output.
Campaign
5 of their 7 ads use free access as the entry point, so reduce trial friction while stating exactly what a new user can accomplish.
What Rhizome is running
Rhizome ads, read · 7 of 7 read one by one · 2026-08-29T08:33:37.348Z
They repeat FDA research, citation volume, and no-hallucination claims across 5 of the 7 ads, while 2 focus on faster document search. You can compete by showing a concrete research workflow and making evidence quality verifiable rather than repeating broad accuracy language. Their free-tier entry point appears in 5 of the 7 ads, so a clear first-use path is a central acquisition move to answer.
- 10
- active ads
- 10%
- video
- 0
- median days running
- 0
- longest run, days
- 10
- creative variants
- not read
- EU reachno detail pass yet
Format
Running for
10 of 10 ads · fetched 2026-08-29 · first run, nothing to compare against
Know what the FDA thinks, without hallucinations. Sign up and ask any question for free.
US
Know what the FDA thinks, without hallucinations. Sign up and ask any question for free.
US
no primary text
US
Rhizome AI
no primary text
US
no primary text
US
no primary text
US
Research receiptSources, retention and creditsHide details
What this run read
12 credits spent
Ad copy and review text are quoted from the linked public pages.
This is a public page on kamplyapp.com. It stays up until its owner takes it down.
